EMMALYN NEWMAN: Open Payments
NPI 1407324593 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 44 payments from 19 companies in 2025. Trend: 2023 $229 · 2024 $1,000 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $126 |
| PFIZER INC. | 6 | $115 |
| GlaxoSmithKline, LLC. | 5 | $80 |
| ABBVIE INC. | 3 | $75 |
| Lilly USA, LLC | 4 | $74 |
| Exact Sciences Corporation | 4 | $67 |
| Astellas Pharma US Inc | 2 | $49 |
| Dexcom, Inc. | 1 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $32 |
Products named: QULIPTA, MOUNJARO, Cologuard Collection Kit, Ozempic, SHINGRIX, ELIQUIS, Veozah, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
